Tag Archives: informed consent
Can Vitamin D Benefit Patients with Prediabetes?
Can Vitamin D Benefit Patients with Prediabetes? No Effect of High-Dose Vitamin D Treatment on β-Cell Function, Insulin Sensitivity, or Glucose Homeostasis in Subjects With Abnormal Glucose Tolerance: A Randomized Clinical Trial Henrik Wagner1⇑, Michael Alvarsson1, Buster Mannheimer2, Marie Degerblad1 and Claes Göran … Continue reading →
True Risk of Serious Harms with Antidepressants Still Uncertain
True Risk of Serious Harms with Antidepressants Still Uncertain http://www.bmj.com/content/352/bmj.i65 Abstract Objective To study serious harms associated with selective serotonin and serotonin-norepinephrine reuptake inhibitors. Design Systematic review and meta-analysis. Main outcome measures Mortality and suicidality. Secondary outcomes were aggressive behaviour and akathisia. Data … Continue reading →
Quetiapine safety in older adults?
Quetiapine safety in older adults? Journal of Clinical Pharmacy and Therapeutics Volume 41, Issue 1, pages 7–18, February 2016 http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12357/abstract Abstract WHAT IS KNOWN AND OBJECTIVE: Quetiapine is a second-generation antipsychotic that is commonly prescribed for a range of approved and off-label indications … Continue reading →
Severe parkinsonism due to Reglan (metoclopramide): the importance of early recognition.
A reminder.. The well-established but under-appreciated dopamine-blocking effect of metoclopramide. Ned Tijdschr Geneeskd. 2013;157(26):A6037. Severe parkinsonism due to Reglan (metoclopramide): the importance of early recognition. [Article in Dutch] de Ronde MW1, Kingma HJ, Munts AG. Author information 1Kennemer Gasthuis, afd. Neurologie, Haarlem, … Continue reading →
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer’s disease
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer’s disease http://nutritionandmetabolism.biomedcentral.com/articles/10.1186/1743-7075-2-28 Ingrid Van der Auwera, Stefaan Wera, Fred Van Leuven et al. Nutrition & Metabolism20052:28 Abstract Background Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that primarily … Continue reading →